Tag: Aurobindo
Browse our exclusive articles!
Aurobindo arm CuraTeQ reports positive Phase 3 results for allergy drug BP11
Aurobindo Pharma’s wholly owned subsidiary, CuraTeQ Biologics, has reported positive top-line results from the Phase 3 trial of its omalizumab biosimilar, BP11, indicating comparable...
Aurobindo Pharma approves ₹800 crore share buyback; Check premium, record date and more
Shares of drugmaker Aurobindo Pharma Ltd. will be in focus on Monday, April 6, after its board has approved a "buyback" of its equity...
Stocks to buy for short term: From DMart, MCX to Aurobindo Pharma— Experts suggest 6 stock picks for next 1-2 weeks
अल्पावधि के लिए खरीदने योग्य स्टॉक: मार्केट बेंचमार्क निफ्टी 50 मार्च में 11% से अधिक गिर गया, वित्तीय वर्ष 2025-26 (FY26) को 5% की...
Aurobindo Pharma’s CuraTeQ signs EU biosimilars distribution pact with STADA
Hyderabad-based drugmaker Aurobindo Pharma Ltd on Wednesday (March 25) said its wholly owned subsidiary CuraTeQ Biologics Pvt Ltd has entered into a marketing and...
Aurobindo Pharma arm receives VAI classification from USFDA for Telangana unit
Aurobindo Pharma Ltd on Friday, March 20, said its wholly owned subsidiary, Apitoria Pharma Pvt Ltd, has received a ‘Voluntary Action Indicated’ (VAI) classification...
